Biohaven Ltd. (BHVN) Q4 2020 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. Welcome to BioHaven Pharmaceuticals' fourth quarter 2020 and full year results call. At this time, all participants' lines are in listen-only mode. After the speaker's presentation, there will be a question and answer session. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please be advised that today's conference call may be recorded. I would now like to hand the conference over to BioHaven's Chief Operating Officer, Clifford Bechtold. Thank you, and you may now begin. Good morning, and thank you. And welcome to the Biohaven's fourth quarter 2020 earnings call. Speaking on today's call are Dr. Vlad Torch, our Chief Executive Officer, Jim Englehart, Chief Financial Officer, Vijay Jones, Chief Commercial Officer, and Dr. Elise Stock, our Chief Medical Officer. Earlier this morning, we issued a press release announcing the fourth quarter 2020 highlights and a summary of our year-end results. A copy of this press release can be found on our website at biohavenfarmer.com and will be on file with the 10Q later filed today. Before we begin, let me remind everybody that today's discussion contains forward-looking statements based on the environment as we currently see it. It includes risks and uncertainties. A list and description of the risks and uncertainties associated with an investment in Biohaven can be found in the company's filings with the U.S. Securities and Exchange Commission. Please be aware that you should not place undue reliance on the forward-looking statements we make today. For this call, we will focus on non-GAAP financial measures with detailed descriptions of GAAP and non-GAAP analysis in our filings. An archive of today's call will be posted on the Live Havens website ...